These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 302143)

  • 41. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity.
    Stoller RG; Hande KR; Jacobs SA; Rosenberg SA; Chabner BA
    N Engl J Med; 1977 Sep; 297(12):630-4. PubMed ID: 302412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites.
    Cadman E; Farber L; Berd D; Bertino J
    Cancer Treat Rep; 1977 Sep; 61(6):1109-16. PubMed ID: 332346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The influence of liver and renal functions on the changes in serum methotrexate (MTX) level in high-dose MTX therapy].
    Sato T; Nakanishi K; Takahashi M; Sato K; Miura T; Kuzuya T; Mizuno M
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2375-9. PubMed ID: 2260874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Phase II trial of high dose methotrexate with citrovorum factor "rescue" for hematological malignancies].
    Ueda T; Kubota Y; Saigo K; Tanaka T; Takubo T; Shibata H; Nakamura H; Masaoka T; Yoshitake J; Ishigami S
    Rinsho Ketsueki; 1982 Jun; 23(6):854-61. PubMed ID: 6983592
    [No Abstract]   [Full Text] [Related]  

  • 45. [High dose methotrexate with citrovorum factor rescue therapy. (2) Measurement of methotrexate and its major metabolite, 7-hydroxymethotrexate in cerebrospinal fluid by high pressure liquid chromatography].
    Tanaka J; Kinpara H; Sasaki K; Fujimoto T
    Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):889-95. PubMed ID: 6604768
    [No Abstract]   [Full Text] [Related]  

  • 46. [Methotrexate-leucovorin rescue therapy: pharmacological characteristics and clinical effective use].
    Fujimoto T
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1901-6. PubMed ID: 8978794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Experiences with enterally and parenterally applied leucovorin following therapy with high doses of methotrexate in malignant tumors (author's transl)].
    Vahrson H; Gorges K
    Med Klin; 1976 Oct; 71(41):1720-3. PubMed ID: 1086422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of high-dose oral methotrexate sequenced at 24 hours with 5-FU: a clinical toxicity study.
    Benz C; Silverberg M; Cadman E
    Cancer Treat Rep; 1983 Mar; 67(3):297-9. PubMed ID: 6831477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase I study of high-dose methotrexate with thymidine and low-dose leucovorin.
    Bruno S; Grindey G; Zakrzewski S; Priore R; Kinahan J; Moayeri H; Ledesma E; Mittelman A; Creaven P
    Cancer Res; 1982 Nov; 42(11):4824-6. PubMed ID: 6982097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases.
    Stovall TG; Ling FW; Gray LA; Carson SA; Buster JE
    Obstet Gynecol; 1991 May; 77(5):749-53. PubMed ID: 2014090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Essential laboratory determinations for monitoring high-dose methotrexate treatment with citrovorum factor rescue.
    Jürgens H; Ebell W; Bachmann R; Kupke I; Richter O; Andräs A; Göbel U
    Pediatr Pharmacol (New York); 1983; 3(3-4):157-65. PubMed ID: 6610851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Weekly high-dose methotrexate with citrovorum factor rescue for non-Hodgkin's lymphoma--serum methotrexate level and safety administration (author's transl)].
    Sasaki K; Fujimoto T; Goya N
    Rinsho Ketsueki; 1979 Jan; 20(1):90-7. PubMed ID: 311390
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil.
    Wiemann MC; Cummings FJ; Kaplan HG; Spremulli EN; Doolittle CH; Calabresi P
    Cancer Res; 1982 Sep; 42(9):3896-900. PubMed ID: 6980707
    [No Abstract]   [Full Text] [Related]  

  • 54. Changes in glomerular filtration rate associated with high-dose methotrexate therapy in adults.
    Howell SB; Carmody J
    Cancer Treat Rep; 1977 Oct; 61(7):1389-91. PubMed ID: 303938
    [No Abstract]   [Full Text] [Related]  

  • 55. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
    Rosen G; Suwansirikul S; Kwon C; Tan C; Wu SJ; Beattie EJ; Murphy ML
    Cancer; 1974 Apr; 33(4):1151-63. PubMed ID: 4544836
    [No Abstract]   [Full Text] [Related]  

  • 56. [Disturbances of coagulation following high-dosage methotrexate with citrovorum factor rescue in patients with osteogenous sarcoma. (author's transl)].
    Göbel U; Jürgens H; von Voss H; Wahn V; Rosen G
    Klin Padiatr; 1981 Mar; 193(2):94-8. PubMed ID: 6971958
    [No Abstract]   [Full Text] [Related]  

  • 57. High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer.
    Greco FA; Fer MF; Richardson RL; Hande KR; Van Boxtel CJ; Oldham RK
    Cancer Chemother Pharmacol; 1978; 1(4):255-7. PubMed ID: 373922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue".
    Capizzi RL; DeConti RC; Marsh JC; Bertino JR
    Cancer Res; 1970 Jun; 30(6):1782-8. PubMed ID: 4248129
    [No Abstract]   [Full Text] [Related]  

  • 59. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
    Etienne MC; Thyss A; Bertrand Y; Rubie H; Milano G
    Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methotrexate with citrovorum factor rescue in gestational trophoblastic disease.
    Wong LC; Choo YC; Ma HK
    Am J Obstet Gynecol; 1985 May; 152(1):59-62. PubMed ID: 2986458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.